IL75904A - Substituted hydroxyalkylazoles,their preparation and pharmaceutical compositions containing them - Google Patents

Substituted hydroxyalkylazoles,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL75904A
IL75904A IL75904A IL7590485A IL75904A IL 75904 A IL75904 A IL 75904A IL 75904 A IL75904 A IL 75904A IL 7590485 A IL7590485 A IL 7590485A IL 75904 A IL75904 A IL 75904A
Authority
IL
Israel
Prior art keywords
optionally substituted
alkyl
hydroxyalkylazoles
substituted
preparation
Prior art date
Application number
IL75904A
Other languages
English (en)
Other versions
IL75904A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL75904A0 publication Critical patent/IL75904A0/xx
Publication of IL75904A publication Critical patent/IL75904A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Epoxy Compounds (AREA)
IL75904A 1984-07-27 1985-07-24 Substituted hydroxyalkylazoles,their preparation and pharmaceutical compositions containing them IL75904A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843427844 DE3427844A1 (de) 1984-07-27 1984-07-27 Substituierte hydroxyalkyl-azole, verfahren zu ihrer herstellung sowie diese enthaltende antimykotische mittel

Publications (2)

Publication Number Publication Date
IL75904A0 IL75904A0 (en) 1985-12-31
IL75904A true IL75904A (en) 1989-08-15

Family

ID=6241791

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75904A IL75904A (en) 1984-07-27 1985-07-24 Substituted hydroxyalkylazoles,their preparation and pharmaceutical compositions containing them

Country Status (9)

Country Link
US (1) US4806559A (xx)
EP (1) EP0169474B1 (xx)
JP (1) JPS6147467A (xx)
KR (1) KR860001081A (xx)
AT (1) ATE37541T1 (xx)
CA (1) CA1249282A (xx)
DE (2) DE3427844A1 (xx)
IL (1) IL75904A (xx)
ZA (1) ZA855639B (xx)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2623129C3 (de) * 1976-05-22 1980-04-10 Nordmark-Werke Gmbh, 2000 Hamburg U-Diphenyl-3-(imidazol-l-yl) -propan-2-ole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0052424B2 (en) * 1980-11-19 1990-02-28 Imperial Chemical Industries Plc Triazole compounds, a process for preparing them, their use as plant fungicides and fungicidal compositions containing them
DE3132335A1 (de) * 1981-08-17 1983-03-03 Bayer Ag, 5090 Leverkusen Substituierte azolyl-phenoxy-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
DE3219041A1 (de) * 1982-05-19 1983-11-24 Bayer Ag, 5090 Leverkusen 1-azolyl-2-oximino-butan-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und pflanzenwachstumsregulatoren
DE3237400A1 (de) * 1982-10-08 1984-04-12 Bayer Ag, 5090 Leverkusen Substituierte 1-hydroxyethyl-triazolyl-derivate
DE3242236A1 (de) * 1982-11-15 1984-05-17 Bayer Ag, 5090 Leverkusen "antimykotische mittel"
DE3245504A1 (de) * 1982-12-09 1984-06-14 Bayer Ag, 5090 Leverkusen Fungizide mittel, deren herstellung und verwendung

Also Published As

Publication number Publication date
IL75904A0 (en) 1985-12-31
ATE37541T1 (de) 1988-10-15
EP0169474A3 (en) 1986-12-30
DE3565260D1 (en) 1988-11-03
KR860001081A (ko) 1986-02-22
JPS6147467A (ja) 1986-03-07
CA1249282A (en) 1989-01-24
EP0169474B1 (de) 1988-09-28
EP0169474A2 (de) 1986-01-29
US4806559A (en) 1989-02-21
DE3427844A1 (de) 1986-02-06
ZA855639B (en) 1986-03-26

Similar Documents

Publication Publication Date Title
AU552373B2 (en) Ether deriviatives of 1-hydroxyalkyl-azoles
HK50395A (en) 4-[4-[4-[4-[[2-(2,4-difluorophenyl)2-(ih-azolylmethyl)-1,3-dioxolan-4-yl]-methoxy)phenyl]-1-piperazinyl]phenyl]triazolones
IL70389A0 (en) Fungicidal compositions containing substituted hydroxyalkyl-azole derivatives and their preparation
IL75904A0 (en) Substituted hydroxyalkylazoles,their preparation and pharmaceutical compositions containing them
PT76661A (en) Process for the preparation of a fungicidal and/or plant growth regulating compositions containing 1-azolyl-2-oximino-butane derivatives
HUT41615A (en) Fungicidal compositions comprising benzaldoxime carbamate derivatives as active substance and process for preparing such compounds
PT77147A (en) Process for the preparation of a fungicidal composition containing azolyl-phenoxy-tetrahydrofuran-2-ylidene-methanes
EP0224056A3 (en) Triazolylglycol ethers, fungicides and bioregulators
ES8206487A1 (es) Procedimiento para la obtencion de 2,4-diclorofenil-imidazol-vinil-cetonas sustituidas
IL68033A0 (en) Substituted azolylethyl oximinoalkyl ethers,their preparation and their use as fungicides